The Patent Finder

Vaximm AG

Also on record
Records under this name other than the patents Vaximm AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 6 of 6 · Back to Vaximm AG

PatentTitleStatus Expires Confidence
US 9,493,738Method for Producing High Yield Attenuated Salmonella Strains
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,821,163Process for the production of a DNA vaccine for cancer immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,590,215Process for the Production of a DNA Vaccine for Cancer Immunotherapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,357,842PD-L1 targeting DNA vaccine for cancer immunotherapy
Lapsed on the fee record
Ended Jun 14, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 14, 2026From the USPTO record
US 9,920,297Salmonella-Based Vectors for Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1
Lapsed on the fee record
Ended Mar 20, 2026 · High confidence
Lapsed on the fee recordEnded Mar 20, 2026High confidence
US 10,815,455Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
Lapsed on the fee record
Ended Oct 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 27, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited